Prevalence of a Linezolid Minimum Inhibitory Concentration of 2 mg/L in Methicillin-Susceptible/Resistant <i>Staphylococcus aureus</i>, <i>Staphylococcus argenteus</i>, Coagulase-Negative <i>Staphylococcus</i>, and <i>Mammaliicoccus</i>
Linezolid (LZD) is an oxazolidinone antibiotic effective in the treatment of infection with Gram-positive bacteria, including methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). The decline in susceptibility to linezolid is a concern for antimicrobial chemotherapy. In this study, the prevalen...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
MDPI AG
2025-12-01
|
| Sraith: | Acta Microbiologica Hellenica |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/2813-9054/70/4/45 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
